As neuroscientists look to the future of their field, they are beginning to delve into more complex factors that define our emotions and intentions.
-
- The Scientist »
- Magazine »
- Features »
Features
Most Recent
In fewer than 15 years, nanomedicine has gone from fantasy to reality.
At the nanoscale old materials acquire new properties that International Institute for Nanotechnology Director Chad Mirkin thinks will change the way medicine is practiced.
Investing more federal dollars in life science research may save the US economy.
History repeats itself, and so do trends in research funding.
Nanotechnology will offer doctors new ways to diagnose and treat patients, boosting efficiency and slashing costs.
Learn about the field’s first genetic circuits and read forecasts by George M. Church and J. Craig Venter of a future where man-made organisms pump out novel fuels, drugs, and therapies.
What does a normally aging brain look like? Are diseases of aging such as Alzheimer’s inevitable?
Researchers and pharma companies have tried to attack this disease by reducing amyloid plaques, but inflammation may be the real culprit.
Subjects
- cancer
- cell & molecular biology
- clinical trials
- culture
- disease/medicine
- funding
- genetics & genomics
- immunology
- microbiology
- neuroscience
Sub Categories
- Bio Business
- Capsule Reviews
- Careers
- Contributors
- Critic At Large
- Editorial
- Features
- Foundations
- Lab Tools
- Modus Operandi
- Notebook
- Profile
- Reading Frames
- Scientist to Watch
- Speaking of Science
- Special Section
- The Literature
- Thought Experiment
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Advertisement
Current Issue
